Clinical trial · Observational
Assessment System of Sarcopenia in Lung Cancer Patients
Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Sarcopenia | — | UNRESOLVED | — |
| Ultrasound | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CT/MRI scan | Diagnostic Test | — | UNRESOLVED |
| ultrasound scan | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Lung cancer patients with sarcopenia
- interventionNames
- Diagnostic Test: ultrasound scan
- Diagnostic Test: CT/MRI scan
- label
- Lung cancer patients without sarcopenia
- interventionNames
- Diagnostic Test: ultrasound scan
- Diagnostic Test: CT/MRI scan
Primary outcomes (2)
- measure
- Death
- timeFrame
- Within 2 years after the initial ultrasound examination
- measure
- Perioperative complications
- timeFrame
- Within 7 days after the surgery.
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: 1. Hospitalized patients scheduled for radical resection of lung cancer. 2. With a CT/MRI examination within 1 week. 3. The compliance of examination was good. Exclusion Criteria: 1. Amputated arm or leg. 2. Severe oedema (oedema higher than knee level). 3. Implantable pacemaker. 4. Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.
References
Publications (0)
Data not yet available